^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    tomaralimab (NM-101)

    i
    Other names: NM-101, OPN-305
    Associations

    News

    Trials
    Company:
    Neuramedy
    Drug class:
    TLR2 antagonist
    Related drugs:
    Associations

    News

    Trials
    8ms
    Phase 1 Single Ascending Dose Study (clinicaltrials.gov)
    P1, N=36, Recruiting, Neuramedy Co. Ltd.
    New P1 trial
    |
    tomaralimab (NM-101)